<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">
x

Development of a Humanized Mouse Model for Direct Evaluation of Anti-Human PD-L1 Antibodies

Therapies that perturb binding of the programmed death-ligand 1 (PD-L1) to its receptor, programmed cell death protein 1 (PD-1), have achieved unprecedented rates of sustained clinical response in patients with various cancer types.